One of five receptors for the signaling lipid S1P, and the specific subtype implicated in directing certain stem cells toward damaged tissue.
S1P signals through a family of five G-protein-coupled receptors — S1PR1 through S1PR5 — each with a different expression pattern across tissues and a different set of downstream effects. This is a common design in cell signaling: a single ligand (S1P) produces different outcomes depending on which receptor subtype and cell type it's acting on.
S1PR2 is one member of this family, and has been the subject of specific research interest in the context of stem cell migration.
Tissue injury and inflammation are associated with local increases in S1P concentration. Cells expressing S1PR2 can, in principle, sense that gradient and migrate toward it — a mechanism proposed as part of how certain circulating or systemically administered stem cell populations locate and move toward sites of damage, sometimes referred to as homing.
This proposed mechanism has been studied specifically in relation to Muse cells, where S1P/S1PR2 signaling has been described in published research as contributing to their migration toward injured tissue after intravenous administration. See Muse Cell Homing Research for a closer look at that body of work.
A proposed homing mechanism is relevant to how a product might be expected to behave after systemic (IV) administration versus site-specific injection — but it describes a biological hypothesis under active research, not a guaranteed clinical outcome. Providers should treat homing research as mechanistic background, not as a substitute for direct clinical evidence for a specific product and indication.
This page is educational reference material for licensed healthcare providers and does not constitute medical, legal, or regulatory advice. HCT/P products are not FDA-approved.